Abstract
Purpose
This systematic review evaluated the efficacy and safety of autologous chondrocyte implantation (ACI) for chondral defects of the knee in skeletally immature patients. Current available data from patients reported outcome measures (PROMs) and complications were collected, analyzed, and discussed.
Methods
This systematic review was conducted according to the PRISMA guidelines. The following databases were accessed in May 2022: PubMed, Google scholar, Embase, and Scopus. All the clinical studies investigating the efficacy of ACI to manage chondral defects of the knee in skeletally immature patients were accessed. Articles treating patients with surgical procedures other than ACI were not eligible, nor were studies with a follow-up shorter than 12 months.
Results
Data from 9 studies (251 procedures) were collected. 32% (80 of 251) of patients were females. The mean length of follow-up was 44.2 ± 29.4 (range, 12–115) months. The mean age of the patients was 16.4 ± 0.7 (range, 15–17) years. The Knee injury and Osteoarthritis Outcome Score (KOOS) and International Knee Document Committee (IKDC) increased of + 41.9/100 (P = 0.003) and + 33.2/100 (P = < 0.0001) points, respectively. The Lysholm Knee Score improved of + 20.6/100 (P = 0.02) points. The Visual Analogue Scale (VAS) for pain reduced of − 3.6/10 (P = 0.004) points. The Tegner scale did not show any statistically significant improvement from baseline to follow-up (P = n.s.). The rate of graft hypertrophy was 12.5% (5 of 40 patients), and the rate of failure 5.6% (8 of 142 patients).
Conclusion
ACI for chondral defects of the knee is effective to improve PROMs in skeletally immature patients. The safety profile of ACI still remains controversial.
Level of evidence
III.
Introduction
Chondral defects of the knee in skeletally immature patients are common and can occur following acute trauma, such as ankle sprain or patellar dislocation [42, 55]. Up to 10% of adolescents and young adults with knee hemarthrosis following acute trauma present a focal chondral damage [2]. Osteochondritis dissecans (OCD) is an idiopathic necrosis in a localized weight-bearing area of epiphyseal cartilage or subchondral bone and is the most common non-traumatic cause of focal chondral defect in skeletally immature patients [9, 18, 28, 58].
The management of chondral defects in young patients is challenging, with limited evidence and unpredictable outcomes. Regardless of its pathogenesis, autologous chondrocyte implantation (ACI) has been widely performed for chondral defects of the knee [17, 38]. ACI is a two-step surgical procedure. Chondrocytes are harvested from a non-weight-bearing zone of the knee in a fully arthroscopic fashion, and expanded externally in a laboratory [34, 41]. In a second surgical session, the chondral defect is debrided, and the expanded chondrocytes are implanted in the defect. A periosteal flap (I generation, pACI) or a collagen membrane (II generation, cACI) is used to retain the expanded chondrocytes into the defect [31, 38]. Matrix-induced ACI (mACI) represents the III generation of procedures: the harvested autologous chondrocytes are seeded and expanded directly on a resorbable membrane, which is subsequently implanted over the defect (mACI) [5, 33, 41, 47]. Current evidence on ACI in skeletally immature patients arises from a limited number of clinical studies, and, to the best of our knowledge, no previous systematic review has been conducted. Therefore, this systematic review evaluated the efficacy and safety profile of ACI for chondral defects of the knee in skeletally immature patients. Current available data from patient-reported outcome measures (PROMs) and complications were collected, analyzed, and discussed. It was hypothesized that ACI for the management of chondral defects of the knee is effective and safe in skeletally immature patients.
Materials and methods
Search strategy
This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA guidelines [46]. The PICOT algorithm was preliminary pointed out:
-
P (Population): adolescents;
-
I (Intervention): chondral repair surgical procedure;
-
C (Comparison): improvement from baseline to last follow-up;
-
O (Outcomes): PROMs and complications;
-
T (Timing): minimum 12 month follow-up.
Data source and extraction
Two independent authors (**;**) performed the literature search. The following databases were accessed in May 2022: PubMed, Google scholar, Embase, and Scopus. The following keywords were used: knee, chondral, cartilage, hyaline, defects, damage, injury, pain, symptoms, surgery, autologous chondrocyte implantation, ACI, management, strategy, therapy, treatment, regeneration, visual analogue scale, reoperation, revision, failure, hypertrophy, and delamination in combination using the Boolean operator (AND/OR). No time constrains were used for the search. The same authors independently performed the initial screening of the resulting titles. If the title and abstract matched the topic, the article full text was accessed. The bibliography of the full-text articles was also screened by hands. Disagreements were debated and mutual solved by consensus.
Eligibility criteria
All the clinical studies investigating the efficacy and safety of ACI to manage chondral defects of the knee in skeletally immature patients were accessed. Articles in English, German, Italian, French, and Spanish were eligible. Levels I–IV of evidence, according to Oxford Centre of Evidence-Based Medicine [20], were considered. Only studies published in peer-reviewed journals were considered. Reviews and meta-analyses, editorials, commentaries, abstracts, and posters were not considered. Articles reporting patients treated with surgical procedures other than ACI were not eligible, nor were studies with follow-up shorter than 12 months. Studies which involved patients with closed growth plates were not considered. Only articles reporting quantitative data on the outcomes of interest were considered in the present systematic review.
Outcomes of interest
Two independent authors (F.M. & J. E.) examined articles resulting from the literature search. Study generalities were collected: author, year, journal, and type of study. Patient baseline data were also retrieved: number of samples, mean BMI and age, mean duration of the symptoms, mean length of the follow-up, percentage of female, and mean size of the defect (cm2). Data with regards to the following PROMs were collected: Knee injury and Osteoarthritis Outcome Score (KOOS) [57], Visual Analogue Scale (VAS), Tegner Activity Scale [8], Lysholm Knee Score [11], and the International Knee Document Committee (IKDC) [22]. Data concerning the rates of failure and graft hypertrophy were also collected.
Methodology quality assessment
The risk of bias was assessed by two authors independently (F.M. & J.E.). The methodological quality assessment was made through “Risk of Bias in Non-randomized Studies of Interventions” (ROBINS-I) scoring system [48]. The following biases were evaluated: confounding, selection of participants, classification of interventions, deviation from intended interventions, missing data, measurement of outcomes, and selection of the reported results.
Statistical analysis
The statistical analyses were conducted by the main author (F.M.) using the software IBM SPSS version 25. For descriptive statistics, the arithmetic mean and standard deviation were used. For continuous variable, the mean difference (MD) effect measure was adopted. The standard error of the mean (SEM) was also evaluated. The confidence interval (CI) was set at 95%. The t test was evaluated, with values of P < 0.05 considered statistically significant.
Results
Search result
The literature search produced 1169 articles. Of them, 301 were excluded as they were duplicates. Additionally, 855 studies were excluded with reason: reported data on other procedures rather than ACI (N = 18), reported data on adults with closed growing plates (N = 801), not compatible design or journal (N = 31), short follow-up (N = 2), and language limitations (N = 3). A further four studies were excluded as they did not report data under the outcomes of interests. Finally, nine studies were included in the present investigation: three prospective and six retrospective clinical investigations (Fig. 1).
Methodological quality assessment
Given the retrospective nature and the lack of control group of most included studies, pre-intervention bias reported a moderate risk of bias. The overall bias at intervention was low. The intervention protocol was well defined in most studies, and no significant deviation from the intervention protocol was detected. Data were satisfactory reported in most included studies, and the clinical outcome assessment was comparable among the intervention groups. The reported results corresponded to the planned protocol in all included studies. Despite some limitations, all studies selected have an acceptable quality assessment (Table 1).
Patient demographics
Data from 251 procedures were collected. 32% (80 of 251) of patients were females. The mean length of follow-up was 44.2 ± 29.4 (range, 12–115) months. The mean age of the patients was 16.4 ± 0.7 (range, 15–17) years. The mean BMI was 23.0 ± 1.2 kg/m2. Generalities of the included studies and patient demographic are shown in Table 2.
Outcomes of interest
KOOS and IKCD increased of + 41.9/100 (P = 0.003) and + 33.2/100 (P = < 0.0001) points, respectively. The Lysholm improved by + 20.6/100 (P = 0.02) points. The VAS reduced by -3.6/10 (P = 0.004) points. The Tegner scale did not show any statistically significant improvement from baseline to follow-up (n.s.). The rate of graft hypertrophy was 12.5% (5 of 40 patients), and the rate of failure 5.6% (8 of 142 patients). Results of PROMs are shown in greater detail in Table 3.
Discussion
According to the main findings of the present systematic review, ACI for chondral defects of the knee is effective to improve PROMs in skeletally immature patients. The mean improvement at last follow-up of the KOOS, IKDC, Lysholm, and VAS overcame their minimally clinically important difference (MCID) [1, 24, 49]. The Tegner scale did not show any statistically significant improvement from baseline to the last follow-up. The overall rate of complications was concerning: 12.5% of patients demonstrated graft hypertrophy and 5.6% of procedures failed. However, only a few authors reported data on the rate of complication. It has been hypothesized that some authors did not state clearly whether complication was found, thus producing an underestimation of the overall rate of complications. Many authors reported data on pACI, which is associated with a greater rate of graft hypertrophy than the other generations of ACI [4, 27, 60]. Moreover, the membrane was sutured in the first two generations of ACI (pACI and cACI) [33]. Although suturing allows a more stable fixation of the membrane, it produces partial-thickness lesions of the articular cartilage which may not heal and may enlarge with time, leading to pain, and premature osteoarthritis [21, 43]. Compared to the previous generations, mACI allows less invasive approaches (mini-arthrotomy or arthroscopy), avoids graft suture, and allows shorter surgical time [39].
At approximately 16 years, the growth plates of the femur start to fuse, and complete bone maturity is evidenced in 88% of subjects within 2 years, and 100% within 3 years [40]. The mean age of the patients included in the present study was 16 years; hence, most of the population had not yet reached bone maturity. In skeletally immature patients, conservative management may alleviate symptoms for a limited period, usually several in months [25].
Skeletally immature patients present higher bone marrow-derived stem cell concentration compared to adults, and regeneration can be stimulated by physiotherapy [3, 15, 54]. In addition, the open epiphyseal growth plates ensure a higher self-healing capability of the lesions (International Cartilage Repair Society, ICRS or Outerbridge grades I or II) [44]. In this respect, bone marrow stimulating procedures should be considered for skeletally immature patients. An isolated microfracture is a bone marrow stimulating technique widely used in adults with smaller defects [7, 56]. The blood clot of microfractures is unstable in bigger defects [14, 16]. To overcome these problems, in 2005, Autologous Matrix-Induced Chondrogenesis (AMIC) has been introduced [6]. In adult patients with focal chondral defects of the knee, AMIC showed promising results at midterm follow-up [35, 36]. AMIC has several advantages compared to ACI. ACI procedures are technically demanding, require two surgical sessions, and are burdened by donor site morbidity, higher costs, and long recovery times. AMIC is a bone marrow stimulating procedure which avoids cartilage harvest and external expansion, and is performed in a single surgical session [36, 37]. However, the current literature lacks studies evaluating bone marrow stimulating procedures in skeletally immature patients, and further studies are recommended.
The present study certainly has limitations. The retrospective nature of most of the included studies carries the risk of selection bias. Given the lack of quantitative data, it was not possible to conduct the statistical analyses including only prospective studies. Although the included studies were methodologically well conducted, most of them involved a limited sample size. The description of the diagnoses, eligibility criteria, and surgical procedures were overall satisfactory in most studies; however, information on rehabilitation protocols was seldom reported and often biased, and the timing of assessing outcome was often unclear. Between studies heterogeneities are evident. One study investigated surgical procedures on patients with chondral defects [12], others combined patients with chondral and osteochondral injuries [19, 29, 45, 59]. The impact on the surgical outcome of adding a subchondral bone procedure to ACI is not fully clarified. Subchondral bone impairment is always present in OCD defects, but not so common following traumatic chondral injuries. One article focused exclusively on patients with OCD [59], and many authors did not clearly state the aetiology of the defects. Whether the aetiology (OCD or trauma) influences the clinical outcome is unclear; given the limited available data, no further subgroup analyses were possible. The location of the defects was variable among the included studies: one study evaluated the patellofemoral joint [59], two the femoral condyles [30, 45], and six investigated mixed locations [12, 13, 19, 29, 51, 52]. Most authors performed the interventions in combination with other procedures [12, 13, 19, 45, 52], or did not clearly state whether the procedures were performed in isolation. A resorbable collagen I/III porcine-derived membrane was used by most authors [12, 13, 19, 29, 45, 52, 59]. One author [19] used 3-dimensional chondrospheres (Spherox), which adhere directly to the subchondral bone without the need of a membrane to stabilize the implant. Two authors combined data of patients who underwent pACI and cACI [12, 29], as they evolved their technique during the patient recruitment. Given the limited data available for inclusion, no further subgroup analyses were possible. The IKDC and the KOOS questionnaires evaluate pain, symptoms, and function in daily life and sport activities, and are widely employed to evaluate patients with chondral defects of the knee [7, 10, 32, 50]. Previous studies demonstrated their validity, reliability, and responsiveness in the adult population [11, 22, 57]. However, the validity of IKDC and KOOS in skeletally immature patients is controversial [23]. Therefore, the child friendly Pedi-IKDC [26] and KOOS-Child were developed and validated [53]. However, none of the included studies referred to the child friendly PROMs, and this represents a further bias. Therefore, these results must be considered within the limitations of the present investigation. Future investigations should validate these results in a clinical setting.
Conclusion
ACI for chondral defects of the knee is effective to improve PROMs in skeletally immature patients. However, the safety profile of ACI still remains controversial, and needs to be clarified by further investigations.
Data availability
The data underlying this article are available in the article and in its online supplementary material.
Abbreviations
- ACI:
-
Autologous chondrocyte implantation
- PROMs:
-
Patient-reported outcome measures
- KOOS:
-
Knee injury and osteoarthritis outcome score
- IKDC:
-
International knee document committee
- VAS:
-
Visual analogue scale
- MD:
-
Mean difference
- SEM:
-
Standard error of the mean
- CI:
-
Confidence interval
- OCD:
-
Osteochondritis dissecans
- pACI:
-
Periosteal flap ACI
- cACI:
-
Collagen membrane ACI
- mACI:
-
Matrix-induced ACI
- n.s.:
-
Not significant
References
Agarwalla A, Liu JN, Garcia GH, Gowd AK, Puzzitiello RN, Yanke AB et al (2020) Return to sport following isolated lateral opening wedge distal femoral osteotomy. Cartilage. https://doi.org/10.1177/19476035209247751947603520924775
Alford JW, Cole BJ (2005) Cartilage restoration, part 1: basic science, historical perspective, patient evaluation, and treatment options. Am J Sports Med 33:295–306
Ball LM, Bernardo ME, Locatelli F, Egeler RM (2008) Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT. Bone Marrow Transplant 42(Suppl 2):S60-66
Barie A, Kruck P, Sorbi R, Rehnitz C, Oberle D, Walker T et al (2020) Prospective long-term follow-up of autologous chondrocyte implantation with periosteum versus matrix-associated autologous chondrocyte implantation: a randomized clinical trial. Am J Sports Med 48:2230–2241
Basad E, Wissing FR, Fehrenbach P, Rickert M, Steinmeyer J, Ishaque B (2015) Matrix-induced autologous chondrocyte implantation (MACI) in the knee: clinical outcomes and challenges. Knee Surg Sports Traumatol Arthrosc 23:3729–3735
Behrens P (2005) Matrixgekoppelte Mikrofrakturierung. Arthroskopie 18:193–197
Bertho P, Pauvert A, Pouderoux T, Robert H, Orthopaedics, Traumatology Society of Western F (2018) Treatment of large deep osteochondritis lesions of the knee by autologous matrix-induced chondrogenesis (AMIC): preliminary results in 13 patients. Orthop Traumatol Surg Res 104:695–700
Briggs KK, Lysholm J, Tegner Y, Rodkey WG, Kocher MS, Steadman JR (2009) The reliability, validity, and responsiveness of the Lysholm score and Tegner activity scale for anterior cruciate ligament injuries of the knee: 25 years later. Am J Sports Med 37:890–897
Brittberg M (2022) Knee osteochondritis dissecans-treatment technical aspects. J Orthop 34:104–110
Brittberg M, Recker D, Ilgenfritz J, Saris DBF, Group SES (2018) Matrix-applied characterized autologous cultured chondrocytes versus microfracture: five-year follow-up of a prospective randomized trial. Am J Sports Med 46:1343–1351
Collins NJ, Misra D, Felson DT, Crossley KM, Roos EM (2011) Measures of knee function: international knee documentation committee (IKDC) subjective knee evaluation form, knee injury and osteoarthritis outcome score (KOOS), knee injury and osteoarthritis outcome score physical function short form (KOOS-PS), knee outcome survey activities of daily living scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), activity rating scale (ARS), and tegner activity score (TAS). Arthritis Care Res (Hoboken) 63(Suppl 11):S208-228
Cvetanovich GL, Riboh JC, Tilton AK, Cole BJ (2017) Autologous chondrocyte implantation improves knee-specific functional outcomes and health-related quality of life in adolescent patients. Am J Sports Med 45:70–76
Dai XS, Cai YZ (2012) Matrix-induced autologous chondrocyte implantation addressing focal chondral defect in adolescent knee. Chin Med J (Engl) 125:4130–4133
de Girolamo L, Schonhuber H, Vigano M, Bait C, Quaglia A, Thiebat G et al (2019) Autologous matrix-induced chondrogenesis (AMIC) and AMIC enhanced by autologous concentrated bone marrow aspirate (BMAC) allow for stable clinical and functional improvements at up to 9 years follow-up: results from a randomized controlled study. J Clin Med 8:392
Giuliani N, Lisignoli G, Magnani M, Racano C, Bolzoni M, Dalla Palma B et al (2013) New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int 2013:312501
Gotze C, Nieder C, Felder H, Migliorini F (2020) AMIC for focal osteochondral defect of the talar shoulder. Life (Basel) 10:328
Grevenstein D, Schafigh D, Oikonomidis S, Eysel P, Brochhausen C, Spies CK et al (2021) Short-term radiological results after spheroid-based autologous chondrocyte implantation in the knee are independent of defect localisation. Technol Health Care. https://doi.org/10.3233/THC-213066
Grimm NL, Weiss JM, Kessler JI, Aoki SK (2014) Osteochondritis dissecans of the knee: pathoanatomy, epidemiology, and diagnosis. Clin Sports Med 33:181–188
Hoburg A, Loer I, Korsmeier K, Siebold R, Niemeyer P, Fickert S et al (2019) Matrix-associated autologous chondrocyte implantation is an effective treatment at midterm follow-up in adolescents and young adults. Orthop J Sports Med 7:2325967119841077
Howick J CI, Glasziou P, Greenhalgh T, Carl Heneghan, Liberati A, Moschetti I, Phillips B, Thornton H, Goddard O, Hodgkinson M (2011) The 2011 Oxford CEBM levels of evidence. Oxford centre for evidence-based medicine. Available at https://www.cebm.net/index.aspx?o=5653. Accessed on Oct 2020
Hunziker EB, Stahli A (2008) Surgical suturing of articular cartilage induces osteoarthritis-like changes. Osteoarthritis Cartilage 16:1067–1073
Irrgang JJ, Anderson AF, Boland AL, Harner CD, Kurosaka M, Neyret P et al (2001) Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med 29:600–613
Iversen MD, von Heideken J, Farmer E, Rihm J, Heyworth BE, Kocher MS (2016) Validity and comprehensibility of physical activity scales for children with sport injuries. J Pediatr Orthop 36:278–283
Jones KJ, Kelley BV, Arshi A, McAllister DR, Fabricant PD (2019) Comparative effectiveness of cartilage repair with respect to the minimal clinically important difference. Am J Sports Med 47:3284–3293
Kaszkin-Bettag M (2013) Is autologous chondrocyte implantation (ACI) an adequate treatment option for repair of cartilage defects in paediatric patients? Drug Discov Today 18:740–747
Kocher MS, Smith JT, Iversen MD, Brustowicz K, Ogunwole O, Andersen J et al (2011) Reliability, validity, and responsiveness of a modified international knee documentation committee subjective knee form (Pedi-IKDC) in children with knee disorders. Am J Sports Med 39:933–939
Kreuz PC, Steinwachs M, Erggelet C, Krause SJ, Ossendorf C, Maier D et al (2007) Classification of graft hypertrophy after autologous chondrocyte implantation of full-thickness chondral defects in the knee. Osteoarthritis Cartilage 15:1339–1347
Kubota M, Ishijima M, Ikeda H, Takazawa Y, Saita Y, Kaneko H et al (2018) Mid and long term outcomes after fixation of osteochondritis dissecans. J Orthop 15:536–539
Macmull S, Parratt MT, Bentley G, Skinner JA, Carrington RW, Morris T et al (2011) Autologous chondrocyte implantation in the adolescent knee. Am J Sports Med 39:1723–1730
Micheli L, Curtis C, Shervin N (2006) Articular cartilage repair in the adolescent athlete: is autologous chondrocyte implantation the answer? Clin J Sport Med 16:465–470
Migliorini F, Berton A, Salvatore G, Candela V, Khan W, Longo UG et al (2020) Autologous chondrocyte implantation and mesenchymal stem cells for the treatments of chondral defects of the knee- a systematic review. Curr Stem Cell Res Ther 15:547–556
Migliorini F, Berton A, Salvatore G, Candela V, Khan W, Longo UG et al (2020) Autologous chondrocyte implantation and mesenchymal stem cells for the treatments of chondral defects of the knee- a systematic review. Curr Stem Cell Res Ther. https://doi.org/10.2174/1574888X15666200221122834
Migliorini F, Eschweiler J, Goetze C, Tingart M, Maffulli N (2021) Membrane scaffolds for matrix-induced autologous chondrocyte implantation in the knee: a systematic review. Br Med Bull 140:50–61
Migliorini F, Eschweiler J, Gotze C, Driessen A, Tingart M, Maffulli N (2022) Matrix-induced autologous chondrocyte implantation (mACI) versus autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the knee: a systematic review. Br Med Bull. https://doi.org/10.1093/bmb/ldac004
Migliorini F, Eschweiler J, Maffulli N, Driessen A, Rath B, Tingart M et al (2021) Management of patellar chondral defects with autologous matrix induced chondrogenesis (AMIC) compared to microfractures: a four years follow-up clinical trial. Life (Basel) 11:141
Migliorini F, Eschweiler J, Maffulli N, Schenker H, Baroncini A, Tingart M et al (2021) Autologous matrix-induced chondrogenesis (AMIC) and microfractures for focal chondral defects of the knee: a medium-term comparative study. Life (Basel) 11:183
Migliorini F, Eschweiler J, Maffulli N, Schenker H, Driessen A, Rath B et al (2021) Autologous matrix induced chondrogenesis (AMIC) compared to microfractures for chondral defects of the talar shoulder: a five-year follow-up prospective cohort study. Life (Basel) 11:224
Migliorini F, Eschweiler J, Schenker H, Baroncini A, Tingart M, Maffulli N (2021) Surgical management of focal chondral defects of the knee: a Bayesian network meta-analysis. J Orthop Surg Res 16:543
Migliorini F, Eschweiler J, Spiezia F, van de Wall BJM, Knobe M, Tingart M et al (2021) Arthroscopy versus mini-arthrotomy approach for matrix-induced autologous chondrocyte implantation in the knee: a systematic review. J Orthop Traumatol 22:23
Migliorini F, Maffulli N (2021) Arthroscopic management of femoroacetabular impingement in adolescents: a systematic review. Am J Sports Med 49:3708–3715
Migliorini F, Maffulli N, Baroncini A, Knobe M, Tingart M, Eschweiler J (2021) Matrix-induced autologous chondrocyte implantation versus autologous matrix-induced chondrogenesis for chondral defects of the talus: a systematic review. Br Med Bull 138:144–154
Migliorini F, Pilone M, Eschweiler J, Marsilio E, Hildebrand F, Maffulli N (2022) High rates of damage to the medial patellofemoral ligament, lateral trochlea and patellar crest after acute patellar dislocation: MRI analysis. Arthroscopy. https://doi.org/10.1016/j.arthro.2022.01.044
Migliorini F, Prinz J, Maffulli N, Eschweiler J, Weber C, Lecoutrier S et al (2022) Fibrin glue does not assist migration and proliferation of chondrocytes in collagenic membranes: an in vitro study. J Orthop Surg Res 17:311
Mithoefer K, Saris DB, Farr J, Kon E, Zaslav K, Cole BJ et al (2011) Guidelines for the design and conduct of clinical studies in knee articular cartilage repair: international cartilage repair society recommendations based on current scientific evidence and standards of clinical care. Cartilage 2:100–121
Mithofer K, Minas T, Peterson L, Yeon H, Micheli LJ (2005) Functional outcome of knee articular cartilage repair in adolescent athletes. Am J Sports Med 33:1147–1153
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
Mohr B, Baldea JD (2022) Knee osteochondritis dissecans. StatPearls, Treasure Island (FL)
Morgan RL, Thayer KA, Santesso N, Holloway AC, Blain R, Eftim SE et al (2018) Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the ‘target experiment’ concept in studies of exposures: rationale and preliminary instrument development. Environ Int 120:382–387
Mostafaee N, Negahban H, Shaterzadeh Yazdi MJ, Goharpey S, Mehravar M, Pirayeh N (2020) Responsiveness of a Persian version of knee injury and osteoarthritis outcome score and tegner activity scale in athletes with anterior cruciate ligament reconstruction following physiotherapy treatment. Physiother Theory Pract 36:1019–1026
Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH (2010) Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 38:1110–1116
Niethammer TR, Holzgruber M, Gulecyuz MF, Weber P, Pietschmann MF, Muller PE (2017) Matrix based autologous chondrocyte implantation in children and adolescents: a match paired analysis in a follow-up over three years post-operation. Int Orthop 41:343–350
Ogura T, Bryant T, Minas T (2017) Long-term outcomes of autologous chondrocyte implantation in adolescent patients. Am J Sports Med 45:1066–1074
Ortqvist M, Roos EM, Brostrom EW, Janarv PM, Iversen MD (2012) Development of the knee injury and osteoarthritis outcome score for children (KOOS-Child): comprehensibility and content validity. Acta Orthop 83:666–673
Palomares Cabeza V, Hoogduijn MJ, Kraaijeveld R, Franquesa M, Witte-Bouma J, Wolvius EB et al (2019) Pediatric mesenchymal stem cells exhibit immunomodulatory properties toward allogeneic t and b cells under inflammatory conditions. Front Bioeng Biotechnol 7:142
Pedowitz JM, Edmonds EW, Chambers HG, Dennis MM, Bastrom T, Pennock AT (2019) Recurrence of patellar instability in adolescents undergoing surgery for osteochondral defects without concomitant ligament reconstruction. Am J Sports Med 47:66–70
Richter DL, Schenck RC Jr, Wascher DC, Treme G (2016) Knee articular cartilage repair and restoration techniques: a review of the literature. Sports Health 8:153–160
Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD (1998) Knee injury and osteoarthritis outcome score (KOOS)–development of a self-administered outcome measure. J Orthop Sports Phys Ther 28:88–96
Rothschild BM, Wayne Lambert H (2021) Distinguishing between congenital phenomena and traumatic experiences: osteochondrosis versus osteochondritis. J Orthop 23:185–190
Teo BJ, Buhary K, Tai BC, Hui JH (2013) Cell-based therapy improves function in adolescents and young adults with patellar osteochondritis dissecans. Clin Orthop Relat Res 471:1152–1158
Zeifang F, Oberle D, Nierhoff C, Richter W, Moradi B, Schmitt H (2010) Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: a randomized clinical trial. Am J Sports Med 38:924–933
Funding
Open Access funding enabled and organized by Projekt DEAL. No external source of funding was used.
Author information
Authors and Affiliations
Contributions
FM: literature search, data extraction, methodological quality assessment, statistical analyses, and writing; NM: supervision, revision, and final approval; JE: literature search, data extraction, and methodological quality assessment; CW, UKH, JP, and FH: supervision. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Not applicable.
Consent to participate.
Not applicable.
Consent for publication.
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Migliorini, F., Eschweiler, J., Prinz, J. et al. Autologous chondrocyte implantation in the knee is effective in skeletally immature patients: a systematic review. Knee Surg Sports Traumatol Arthrosc 31, 2518–2525 (2023). https://doi.org/10.1007/s00167-022-07212-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-022-07212-y
Keywords
- Autologous chondrocyte implantation
- ACI
- Young
- Pediatric
- Skeletally immature